Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

115.20 +1.38 (+1.21%)
Official Closing Price Updated: 7:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,579,232
Open 115.16
Bid (Size) 114.80 (4)
Ask (Size) 115.54 (1)
Prev. Close 113.82
Today's Range 114.36 - 117.30
52wk Range 99.14 - 134.63
Shares Outstanding 2,531,374,696
Dividend Yield 2.53%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio?
12 worst-performing large-cap stocks in the last week. Symbotic, Intel, Snap, Moderna, Mobileye, Pinterest, Arm, Entegris, Atlassian, MicroStrategy, New Oriental, and Western Digital. 
Via Benzinga
2 Ultra-High-Yield Dividend Stocks to Buy in August and Hold at Least a Decade
With an average yield above 7% at recent prices, these stocks could give your passive income stream a big boost. 
Via The Motley Fool

Performance

YTD
+1.73%
+1.73%
1 Month
-8.90%
-8.90%
3 Month
-9.70%
-9.70%
6 Month
-8.70%
-8.70%
1 Year
+9.71%
+9.71%

More News

Read More
MarketBeat Week in Review – 7/29 - 8/2
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Decoding Merck & Co's Options Activity: What's the Big Picture?
Via Benzinga
Merck Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
Analyzing Merck & Co In Comparison To Competitors In Pharmaceuticals Industry
Via Benzinga
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
Via Benzinga
Exposures COVID-19
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
Via InvestorPlace
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
Via Benzinga
Top 3 Health Care Stocks That Are Set To Fly This Quarter
Via Benzinga
IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer
From Daiichi Sankyo
Via Business Wire
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?
Via InvestorPlace
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
Via The Motley Fool
Nasdaq Tumbles Amid Decline In Tech Stocks: Greed Index Moves To 'Fear' Zone
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Merck (MRK) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
Via Benzinga
Exposures COVID-19
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Via Benzinga
Pharma Stock Cuts Earnings Outlook: Still a Buying Opportunity
Via MarketBeat
MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
4 Stocks to Keep High on Your Buy List
Via The Motley Fool
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.